Rovi Says It’s Investigating Moderna Vaccine Incident in Japan

Laboratorios Farmaceuticos Rovi says it’s investigating report of particulate seen in certain Moderna Covid-19 vaccine vials distributed in Japan.

• The origin of this incident may be in one of its manufacturing lines, Rovi says in a regulatory filing Thursday
• Incident refers to certain vials of one product lot distributed exclusively in Japan
• Rovi, as well as Moderna and Takeda, the company distributing the referred vaccine in Japan, are working with health authorities in order to clarify the incident
• NOTE Earlier: Rovi Shares Drop After Moderna Vaccine Batch Suspension in Japan

To contact the reporter on this story:
Charles Penty in ...